ReviewJournal of labelled compounds & radiopharmaceuticals2019
Manganese in PET imaging: Opportunities and challenges.
Review in Journal of labelled compounds & radiopharmaceuticals, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 40 citations in OpenAlex.
- Pyridinophane Ligands: An Attractive Chelator Platform for Mn-Based Imaging Agents.Journal of medicinal chemistry · 2026Article
- PET imaging ofScientific reports · 2025Article
- HER2 expression in different cell lines at different inoculation sites assessed by [Pathology oncology research : POR · 2025Article
- Novel Molecular Classification of Breast Cancer with PET Imaging.Medicina (Kaunas, Lithuania) · 2024Review
- PET imaging of [52 Mn]Mn-DOTATATE and [52 Mn]Mn-DOTA-JR11.Research square · 2024Article
- Cyclotron production of manganese-52: a promising avenue for multimodal PET/MRI imaging.EJNMMI radiopharmacy and chemistry · 2024Article
- Anticancer Metallocenes and Metal Complexes of Transition Elements from Groups 4 to 7.Molecules (Basel, Switzerland) · 2024Review
- Metal ions in biomedically relevant macromolecular structures.Frontiers in chemistry · 2024Review
- Intranasal delivery of imaging agents to the brain.Theranostics · 2024Review
- Longitudinal manganese-enhanced magnetic resonance imaging of neural projections and activity.NMR in biomedicine · 2022Review
- Porphyrins as Chelating Agents for Molecular Imaging in Nuclear Medicine.Molecules (Basel, Switzerland) · 2022Review
- A New Oxygen Containing Pyclen-Type Ligand as a Manganese(II) Binder for MRI andMolecules (Basel, Switzerland) · 2022Article
- Manganese in Diagnostics: A Preformulatory Study.Pharmaceutics · 2022Article
- The Race for Hydroxamate-Based Zirconium-89 Chelators.Cancers · 2021Review
- In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer's disease.Scientific reports · 2021Article
- ImmunoPET: Concept, Design, and Applications.Chemical reviews · 2020Review
- Manganese in PET imaging: Opportunities and challenges.Journal of labelled compounds & radiopharmaceuticals · 2019Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several radionuclides of the transition metal manganese are known and accessible. Three of them,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.